The Use of Valrubicin for the Chemoresection of Superficial Bladder Cancer – A Marker Lesion Study

D. Newling,J. Hetherington,S.K. Sundaram,M.R.G. Robinson,L. Kisbenedek

The Use of Valrubicin for the Chemoresection of Superficial Bladder Cancer – A Marker Lesion Study

2001

D. Newling
J. Hetherington
S.K. Sundaram
M.R.G. Robinson
L. Kisbenedek

Objectives: To assess the effect and tolerance of a 6–week course of intravesical valrubicin on a tumour intentionally left in the bladder (marker lesion) following incomplete trans

Keywords:

Carcinoma in situ
Urology
Urinary bladder
Valrubicin
Pathology
Cancer
Lesion
Urethra
Transitional cell carcinoma
Bladder cancer
Medicine
Chemotherapy
superficial bladder cancer
Prospective cohort study

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations